Synergistic effect of novel HDAC inhibitors with chemotherapy drugs in acute myeloid leukemia
Acute myeloid leukemia (AML) is a highly heterogeneous malignant disease characterized by uncontrolled proliferation, differentiation arrest and accumulation of immature myeloid progenitors. Despite recent developments and the approval of new therapeutic agents in the last few years, outcome remains...
Main Authors: | Giménez-Camino, N. (Naroa), Aguirre-Ena, X. (Xabier), Planes-Pedreño, F.J. (Francisco Javier) |
---|---|
Format: | info:eu-repo/semantics/doctoralThesis |
Language: | eng |
Published: |
Servicio de Publicaciones. Universidad de Navarra.
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/64815 |
Similar Items
-
Comparative pharmacology of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
by: Azanza, J.R. (José Ramón), et al.
Published: (2022) -
Interpretable precision medicine for acute myeloid leukemia
by: Gimeno-Combarro, M. (Marian), et al.
Published: (2023) -
Understanding niche-leukemia interactions: the bone marrow microenvironment regulates the metabolic and redox balance in acute myeloid leukemia stem cells
by: Ana Cristina, et al.
Published: (2023) -
Genetic Polymorphisms Associated to Folate Transport as Predictors of Increased Risk for Acute Lymphoblastic Leukemia in Mexican Children
by: Zaruma Torres, Fausto Leonardo
Published: (2018) - The Leukemias: etiology, pathophysiology, and treatment